Rapid Micro Biosystems (RPID) Capital Expenditures (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Rapid Micro Biosystems | 89.50 Mn | 66.56 Mn | 371,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.87% |
| Dec 31, 2025 | -86.53% |
| Sep 30, 2025 | 379.92% |
| Jun 30, 2025 | -176.49% |
| Mar 31, 2025 | 13.52% |
| Dec 31, 2024 | 127.66% |
| Sep 30, 2024 | -321.35% |
| Jun 30, 2024 | -21.54% |
| Mar 31, 2024 | 39.95% |
| Dec 31, 2023 | -7.73% |
| Sep 30, 2023 | 110.70% |
| Jun 30, 2023 | -71.67% |
| Mar 31, 2023 | -88.72% |
| Dec 31, 2022 | 255.37% |
| Sep 30, 2022 | -317.75% |
| Jun 30, 2022 | -15.47% |
| Mar 31, 2022 | 19.68% |
| Dec 31, 2021 | 328.32% |
| Sep 30, 2021 | -15.16% |
| Jun 30, 2021 | 115.54% |
| Mar 31, 2021 | -5.28% |
| Dec 31, 2020 | 170.11% |